Genetic susceptibility to vaginal candidiasis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Medical Mycology

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/MMY.41.2.143.147PMID 12964847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model.

  2002cited by this paper
• Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma.

  2000cited by this paper
• Major histocompatibility haplotype does not impact the course of experimentally induced murine vaginal candidiasis.

  1999cited by this paper
• Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization

  1999cited by this paper
• Genetic variation in susceptibility to endocrine disruption by estrogen in mice.

  1999cited by this paper
• Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection.

  1998cited by this paper
• Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.

  1998cited by this paper
• Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.

  1998cited by this paper
• Efficacy of syringomycin E in a murine model of vaginal candidiasis.

  1998cited by this paper
• Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis

  1997cited by this paper
• Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load

  1996cited by this paper
• Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens.

  1995cited by this paper
• Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice

  1995cited by this paper
• Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections

  1995cited by this paper
• Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine.

  1994cited by this paper
• Synergy between cilofungin and amphotericin B in a murine model of candidiasis

  1991cited by this paper
• Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis

  1990cited by this paper
• Quantification of vaginal Candida albicans infections in rodents.

  1986cited by this paper
• Increase of mouse resistance to Candida albicans infection by thymosin alpha 1

  1982cited by this paper
• Immune Responses to Candida albicans in Genetically Distinct Mice

  1982cited by this paper
• Susceptibility differences of inbred strains of mice to blastomycosis

  1981cited by this paper
• Strain differences in resistance to infection reversed by route of challenge: studies in blastomycosis

  1981cited by this paper
• Genetic control of susceptibility to Cryptococcus neoformans in mice.

  1980cited by this paper

• Emerging Trends in Hydrogels for the Treatment of Vaginal Candidiasis: A Comprehensive Review.

  2025cites this paper
• Clotrimazole-induced shifts in vaginal bacteriome and lipid metabolism: insights into recovery mechanisms in vulvovaginal candidiasis.

  2024cites this paper
• Impaired neutrophil extracellular trap-forming capacity contributes to susceptibility to chronic vaginitis in a mouse model of vulvovaginal candidiasis

  2024cites this paper
• Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome

  2023cites this paper
• In vivo studies could not confirm in vitro prophylactic synergism between Moringa essential oil and Lactobacillus reuteri (MT180537).

  2022cites this paper
• Methods Related to the Immunopathogenesis of Vulvovaginal Candidiasis and Associated Neutrophil Anergy.

  2022cites this paper
• ANTIFUNGAL DRUG FORMULATION FOR VAGINAL YEAST INFECTION

  2022cites this paper
• α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans

  2021cites this paper
• A therapeutic effect of Nigella sativa extract on female Wistar rats vulvovaginal candidiasis model.

  2020cites this paper
• Update Vaginalmykose

  2020cites this paper
• The Effectiveness of Topical Propolis Administration in the Treatment of Vulvovaginal Candidiasis in Mouse Model Experiments

  2020cites this paper
• The Neutral Vaginal pH in Mice That Is Typical of Most Mammalian Species Should Not Deter Research Using Experimental Murine Models of Candida Vaginitis

  2020cites this paper
• Interspecies differences of candida species causing recurrent vulvovaginal candidiasis in response to fluconazole treatment

  2017cites this paper
• Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: “Neutrophil Anergy”

  2017cites this paper
• Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis

  2017cites this paper
• History of antifungals

  2016cites this paper
• Experimental animal models of invasive fungal infections

  2016cites this paper
• Animal Models to Evaluate Anti-infective Pharmacodynamics

  2016cites this paper
• Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.

  2015cites this paper
• Profile and Susceptibility to Vaginal Yeast of Women Met on a Gynecology Outpatient Clinic

  2015cites this paper
• A study of isolation and identification of non -albicans Candida species from clinically suspected cases of vulvovaginitis

  2014cites this paper
• Coping with chronic vulvovaginal candidiasis

  2014cites this paper
• Immunopathogenesis of vulvo-vaginal candidiasis in human immunodeficiency virus infected women.

  2014cites this paper
• Vulvovaginal Candidiasis as a Chronic Disease: Diagnostic Criteria and Definition

  2014cites this paper
• Reporters for the analysis of N-glycosylation in Candida albicans

  2013cites this paper
• Mouse Strain-Dependent Differences in Estrogen Sensitivity During Vaginal Candidiasis

  2013cites this paper
• Murine model of concurrent oral and vaginal Candida albicans colonisation.

  2012cites this paper
• Perfil fenotípico, diferenciação molecular, produção de enzimas e sensibilidade aos antifúngicos de amostras de leveduras isoladas em três grupos amostrais: mulheres assintomáticas, com candidíase vulvovaginal primária e recorrente

  2012cites this paper
• Chronic vulvovaginal candidiasis: What we know and what we have yet to learn

  2012cites this paper
• Susceptibility to Progressive Cryptococcus neoformans Pulmonary Infection Is Regulated by Loci on Mouse Chromosomes 1 and 9

  2012cites this paper
• Host-Fungus Interactions: Methods and Protocols

  2012cites this paper
• Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

  2012cites this paper
• Efficacy of Recombinant Human Mannose Binding Lectin Alone and in Combination with Itraconazole Against Murine Candida albicans vaginitis

  2011cites this paper
• Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis

  2011cites this paper
• Vulvovaginal Candidiasis in Postmenopausal Women: The Role of Hormone Replacement Therapy

  2011cites this paper
• Caracterização do pontencial biológico de Leiothrix spiralis Ruhland E Syngonanthus nitens (Bong.) Ruhland (Eriocaulaceae)

  2011cites this paper
• Antimicrobial activity of human seminal plasma and seminal plasma proteins

  2010cites this paper
• La candidose vulvovaginale : revue

  2010cites this paper
• Effect of experimental diabetes on the development and maintenance of vulvovaginal candidiasis in female rats.

  2009cites this paper
• Efficacy of CIM 1166, a combination of compounds derived from Mentha spp. in alleviating experimental vulvovaginal candidiasis in mice

  2009cites this paper
• Efficacy of Albaconazole against Candida albicans in a Vaginitis Model

  2009cites this paper
• , in a Vaginitis Model albicans Candida Efficacy of Albaconazole against

  2009cites this paper
• Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.

  2009cites this paper
• Vaginal Microbiota of Women with Frequent Vulvovaginal Candidiasis

  2009cites this paper
• Animal models of mucosal Candida infection.

  2008cites this paper
• Mannose‐binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis

  2008cites this paper
• Protective and pathologic immune responses against Candida albicans infection.

  2008cites this paper
• Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions.

  2007cites this paper
• Vulvovaginal candidosis.

  2007cites this paper
• Genes and gene pathways in Candida infection

  2007cites this paper
• Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.

  2007cites this paper
• History and Update on Host Defense Against Vaginal Candidiasis

  2007cites this paper
• Animal models: an important tool in mycology

  2007cites this paper
• Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis.

  2006cites this paper
• Strain differences influence murine pulmonary responses to Stachybotrys chartarum.

  2006cites this paper
• Innate and Adaptive Cell-Mediated Immunity against Vaginal Candidiasis

  2005cites this paper
• Vaginal discharge reviewed: the adult pre-menopausal female

  2005cites this paper
• History and new insights into host defense against vaginal candidiasis.

  2004cites this paper
• An Intravaginal Live Candida Challenge in Humans Leads to New Hypotheses for the Immunopathogenesis of Vulvovaginal Candidiasis

  2004cites this paper
• Genetic Susceptibility of Mice to Candida albicans Vaginitis Correlates with Host Estrogen Sensitivity

  2004influential citation
• Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model.

  2002cites this paper